During the 62nd ASH Annual Meeting and Exposition, the GvHD Hub was pleased to speak to Ali Bazarbachi, American University of Beirut, Beirut, LB, about the new advances for treating acute GvHD.
During the 62nd ASH Annual Meeting and Exposition, the GvHD Hub was pleased to speak to Ali Bazarbachi, American University of Beirut, Beirut, LB, about the new advances for treating acute GvHD.
What is new for treating acute GvHD?
In this video, Bazarbachi discusses the results of a study evaluating the fecal microbiota transfer product MaaT013, a pooled-donor, full-ecosystem microbiota biotherapeutic, for the treatment of 29 patients with intestinal acute GvHD as part of a compassionate use/expanded access treatment program.
Subscribe to get the best content related to GvHD delivered to your inbox